IRIS
KERLERO DE ROSBO, NICOLE HENRIETTE MADELEINE CLAUDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.477
Totale 2.477
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.477
Totale 2.477
Salva come PNG Salva come JPEG
Città #
Genova 1.413
Genoa 427
Rapallo 368
Vado Ligure 248
Bordighera 21
Totale 2.477
Salva come PNG Salva come JPEG
Nome #
IFN-γ orchestrates mesenchymal stem cell plasticity through the signal transducer and activator of transcription 1 and 3 and mammalian target of rapamycin pathways 155
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 146
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis. 137
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation 127
X-Ray Phase Contrast Tomography Reveals Early Vascular Alterations and Neuronal Loss in a Multiple Sclerosis Model 126
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 124
Exploring Alzheimer's disease mouse brain through X-ray phase contrast tomography: From the cell to the organ 121
Teriflunomide treatment reduces B cells in patients with MS. 118
Mesenchymal stem cells (MSC) as a strategy for the treatment of multiple sclerosis and other diseases of the central nervous system 106
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis 105
Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure 98
Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice 96
Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system. 87
SIRT6 inhibition as a therapeutic approach for treating multiple sclerosis 87
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis. 85
Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS 84
miRNAs shuttled by exosomes derived from primed-MSCs affect the activated-microglia phenotype and possibly support the therapeutic effects of MSC administration in SOD1G93A mice 82
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 73
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cells 70
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cell 70
Mesenchymal Stem Cells for the Treatment ofMultipleSclerosis 69
Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation 67
Neuroinflammation induces synaptic scaling through IL-1β-mediated activation of the transcriptional repressor REST/NRSF 46
Mesenchymal stem cells instruct a beneficial phenotype in reactive astrocytes 43
Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response 38
Different Susceptibility of T and B Cells to Cladribine Depends On Their Levels of Deoxycytidine Kinase Activity Linked to Activation Status 38
Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS 37
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells rescue glial activation in in-vitro models of amyotrophic lateral sclerosis 30
Therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 28
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 22
A neural connection between AgRP neurons and stromal cells in bone marrow and thymus controls lymphoid hematopoiesis and Treg generation 16
MSC-derived extracellular vesicles for the treatment of ALS 13
Neuronal excitability as a potential therapeutical target for Multiple Sclerosis 13
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 10
In-vitro and in-vivo studies showing the beneficial effects of extracellular vesicles derived from mesenchymal stem cells on the reactive astrocyte activation in amyotrophic lateral sclerosis 9
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 8
null 1
Totale 2.585
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.655
article - articoli 7.037
book - libri 0
conference - conferenze 2.167
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 451
Totale 19.310
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020472 0 0 0 0 46 63 83 45 57 104 62 12
2020/2021199 14 17 13 18 8 9 17 26 12 18 20 27
2021/2022345 24 12 15 26 32 18 10 69 20 44 14 61
2022/2023468 35 49 7 55 64 68 8 29 66 11 53 23
2023/2024324 8 28 14 35 31 56 28 31 6 6 16 65
2024/2025286 54 46 15 76 95 0 0 0 0 0 0 0
Totale 2.585